1,3-DIARYL SUBSTITUTED UREAS AS MODULATORS OF KINASE ACTIVITY

PROBLEM TO BE SOLVED: To provide an effective substance for treating disease or disorder responsive to angiogenesis kinase activity modulation, for example, cancers such as breast neoplasia, endometrial cancer, colon cancer, and neck squamous cell carcinoma.SOLUTION: This invention relates to compou...

Full description

Saved in:
Bibliographic Details
Main Authors MITCHELL SCOTT A, BRITTELLI DAVID R, DANCA MIHAELA DIANA, DESIMONE ROBERT W, BLOMGREN PETER A, PIPPIN DOUGLAS A I
Format Patent
LanguageEnglish
Published 07.02.2013
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:PROBLEM TO BE SOLVED: To provide an effective substance for treating disease or disorder responsive to angiogenesis kinase activity modulation, for example, cancers such as breast neoplasia, endometrial cancer, colon cancer, and neck squamous cell carcinoma.SOLUTION: This invention relates to compounds of Formula 1 and pharmaceutically acceptable salts, solvates, crystal forms, chelates, non-covalent complexes, prodrugs, and mixtures thereof.
Bibliography:Application Number: JP20120208429